CompaniesBioNevia Pharmaceuticals

BioNevia Pharmaceuticals

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (3)
View all

Total Trials

3

As Lead Sponsor

2

As Collaborator

1

Total Enrollment

121

By Phase

PHASE1: 3

By Status

COMPLETED: 2TERMINATED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Today
NCT01684241
NCT02035956
NCT03871348
Hover over trial bars to see details

Recent Trials

NCT03871348Collaborator
A First-in-Human Dose Escalation and Expansion Study to Evaluate Intratumoral Administration of SAR441000 as Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors
PHASE1Terminated
77 participants
Started: Jan 3, 2019 · Completed: Feb 21, 2024
NCT02035956Lead Sponsor
IVAC MUTANOME Phase I Clinical Trial
PHASE1Completed
15 participants
Started: Dec 31, 2013 · Completed: Oct 31, 2019
NCT01684241Lead Sponsor
RBL001/RBL002 Phase I Clinical Trial
PHASE1Completed
29 participants
Started: Jun 30, 2012 · Completed: Jul 31, 2015